Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

Tijssen Ruben Y. G.; van der Schaaf Rene J.; Kraak Robin P.; Vink Maarten A.; Hofma Sjoerd H.; Arkenbout Karin; Weevers Auke P. J. D.; Kerkmeijer Laura S. M.; Serruys Patrick W.; Onuma Yoshinobu; Beijk Marcel A. M.; Koch Karel T.; Baan Jan Jr.; Vis M. Marije; Piek Jan J.; Tijssen Jan G. P.; Henriques Jose P. S.; de Winter Robbert J.; Wykrzykowska Joanna J.

首页> 外文期刊>JACC. Cardiovascular interventions >Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

【24h】

Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

机译：患有急性冠状动脉综合征与稳定冠状动脉疾病的患者患者的临床结果，对吸收生物吸收血管支架的临床结果与肺泡药物洗脱金属支架。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《JACC. Cardiovascular interventions》 |2019年第19期|共1页
作者
Tijssen Ruben Y. G.; van der Schaaf Rene J.; Kraak Robin P.; Vink Maarten A.; Hofma Sjoerd H.; Arkenbout Karin; Weevers Auke P. J. D.; Kerkmeijer Laura S. M.; Serruys Patrick W.; Onuma Yoshinobu; Beijk Marcel A. M.; Koch Karel T.; Baan Jan Jr.; Vis M. Marije; Piek Jan J.; Tijssen Jan G. P.; Henriques Jose P. S.; de Winter Robbert J.; Wykrzykowska Joanna J.;
展开▼
作者单位

Amsterdam UMC Amsterdam Netherlands;

OLVG Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

OLVG Amsterdam Netherlands;

MCL Leeuwarden Netherlands;

Tergooi Blaricum Netherlands;

ASZ Dordrecht Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Imperial Coll London England;

Erasmus MC Rotterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

Amsterdam UMC Amsterdam Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study. [J] . Tijssen Ruben Y. G., van der Schaaf Rene J., Kraak Robin P., JACC. Cardiovascular interventions . 2019,第4Suppla19期

机译：患有急性冠状动脉综合征与稳定冠状动脉疾病的患者患者的临床结果，对吸收生物吸收血管支架的临床结果与肺泡药物洗脱金属支架。
2. Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design [J] . WoudstraP., GrundekenM.J., KraakR.P., The American heart journal . 2014,第2期

机译：Amsterdam Investigator-initiateD Absorb策略所有患者试验（AIDA试验）：一项临床评估，比较了ABSORB依维莫司洗脱生物可吸收血管支架策略与XIENCE系列（XIENCE PRIME或XIENCE Xpedition）依维莫司洗脱冠状动脉支架策略的疗效和性能连续性所有患者的冠状动脉病变的治疗：原理和研究设计
3. TCT-310 Four-Year Clinical Outcomes From Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial [J] . Runlin Gao Journal of the American College of Cardiology . 2018,第13期

机译：TCT-310 Aptimus洗脱生物可吸收血管支架随机比较的四年临床结果来自吸收中国审判的冠状动脉疾病患者患者血管内洗脱的金属支架
4. Once-daily Nadroparin Versus Twice-daily Nadroparin in the Treatment of Patients with Acute Coronary Syndromes: The SAFRAX Study [C] . V. Hricak, A. Leizorovic International Congress on Thrombosis . 2006

机译：每日一日奈多林与每次每日Nadroparin治疗患者急性冠状动脉综合征患者：Safrax研究
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Bioresorbable vascular scaffold versus metallic stent in percutaneous coronary intervention: results of the AIDA trial [O] . Syed Raza Shah, Mazia Fatima, Amin Muhammad Dharani, 2017

机译：经皮冠状动脉介入治疗中可生物吸收的血管支架与金属支架：AIDA试验的结果
7. Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design [O] . Woudstra, Pier, Grundeken, Maik J., Kraak, Robin P., 2014

机译：Amsterdam Investigator-initiateD Absorb Strategy All-comers试验（AIDA试验）：一项临床评估，比较了ABSORB依维莫司洗脱生物可吸收性血管支架策略与XIENCE系列（XIENCE PRIME或XIENCE Xpedition）依维莫司洗脱冠状动脉支架治疗的疗效和性能来的所有患者冠状动脉病变的治疗：原理和研究设计

Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

著录项

相似文献

相关主题

期刊订阅